Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
tremelimumab astrazeneca
astrazeneca ab - tremelimumab - carcinom, ikke-småcellet lunge - antineoplastiske midler - tremelimumab astrazeneca in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
certican 0,5 mg tabletter
novartis healthcare a/s - everolimus - tabletter - 0,5 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
certican 0,75 mg tabletter
novartis healthcare a/s - everolimus - tabletter - 0,75 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
certican 0,25 mg tabletter
novartis healthcare a/s - everolimus - tabletter - 0,25 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
everolimus "stada" 10 mg tabletter
stada arzneimittel ag - everolimus - tabletter - 10 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
everolimus "stada" 5 mg tabletter
stada arzneimittel ag - everolimus - tabletter - 5 mg